Aim To perform a baseline survey on condition-specific information access among patients/parents/caregivers with rare endocrine disorders (RD) in Europe. Methods Electronic invitation to participate in a survey (19 questions) was sent to 120 patient advocacy groups (PAGs), and further distributed to 32 European countries. Results A total of 1138 respondents from 22 countries (74% women), aged between 1 year (parents) and 70 years, participated. The Netherlands, France, Germany, Italy and France had highest participation rates. All Main Thematic Groups (MTGs) were represented; the adrenal (32%), pituitary (26%) and thyroid (22%) were the most common. The majority of the respondents got information from their endocrinologist (75%), PAGs (37%)...
The current study aims to assess the development of the knowledge generation program of the European...
Purpose: Rare diseases affect <1 in 2000 people. Despite their rarity, they collectively affect ~30 ...
Background: Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric...
Objective: The European Reference Network on Rare Endocrine Conditions (Endo-ERN), operational since...
Purpose European Reference Network on Rare Endocrine Conditions' (Endo-ERN) mission is to reduce and...
Objective Given that volumes of patients and interventions are important criteria to qualify as a re...
The official installation of the European Reference Networks in 2017 formed the foundation to improv...
Rare endocrine pathology is manifested by either a deficiency or excess of one or more hormones. The...
Objective The European Registries for Rare Endocrine Conditions (EuRRECa, eurreb.eu) includes an e-...
Objective: To identify cross-border international registries for rare endocrine conditions that are ...
International audienceContextDiagnosis announcement of a chronic disease is a crucial moment for pat...
Patient journeys are instruments developed by EURORDIS, The Voice of Rare Disease Patients in Europe...
The aim of the European Reference Network for Rare Endocrine Disorders (Endo-ERN) is to ensure equal...
The current study aims to assess the development of the knowledge generation program of the European...
Purpose: Rare diseases affect <1 in 2000 people. Despite their rarity, they collectively affect ~30 ...
Background: Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric...
Objective: The European Reference Network on Rare Endocrine Conditions (Endo-ERN), operational since...
Purpose European Reference Network on Rare Endocrine Conditions' (Endo-ERN) mission is to reduce and...
Objective Given that volumes of patients and interventions are important criteria to qualify as a re...
The official installation of the European Reference Networks in 2017 formed the foundation to improv...
Rare endocrine pathology is manifested by either a deficiency or excess of one or more hormones. The...
Objective The European Registries for Rare Endocrine Conditions (EuRRECa, eurreb.eu) includes an e-...
Objective: To identify cross-border international registries for rare endocrine conditions that are ...
International audienceContextDiagnosis announcement of a chronic disease is a crucial moment for pat...
Patient journeys are instruments developed by EURORDIS, The Voice of Rare Disease Patients in Europe...
The aim of the European Reference Network for Rare Endocrine Disorders (Endo-ERN) is to ensure equal...
The current study aims to assess the development of the knowledge generation program of the European...
Purpose: Rare diseases affect <1 in 2000 people. Despite their rarity, they collectively affect ~30 ...
Background: Although differentiated thyroid carcinoma (DTC) is the most frequent endocrine pediatric...